Cargando…

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system

INTRODUCTION: The prospect of therapeutic applications of the induced pluripotent stem cells (iPSCs) is based on their ability to generate virtually any cell type present in human body. Generation of iPSCs from somatic cells has opened up new possibilities to investigate stem cell biology, to better...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drozd, Anna M., Walczak, Maciej P., Piaskowski, Sylwester, Stoczynska-Fidelus, Ewelina, Rieske, Piotr, Grzela, Dawid P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515927/ https://www.ncbi.nlm.nih.gov/pubmed/26088261 http://dx.doi.org/10.1186/s13287-015-0112-3

Ejemplares similares

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors
por: Walczak, Maciej P., et al.
Publicado: (2016)

SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence
por: Winiecka-Klimek, Marta, et al.
Publicado: (2015)

HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus
por: Dheekollu, Jayaraju, et al.
Publicado: (2016)

Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells
por: Askautrud, Hanne A, et al.
Publicado: (2009)

IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis
por: Rosiak, Kamila, et al.
Publicado: (2016)

Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy
por: Suzuki, Hitoshi, et al.
Publicado: (2009)

Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 – new vectors for in vitro and in vivo delivery
por: Magin-Lachmann, Christine, et al.
Publicado: (2003)

EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
por: Treda, Cezary, et al.
Publicado: (2016)

Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
por: Grot, Dagmara, et al.
Publicado: (2022)

Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line
por: STOCZYNSKA-FIDELUS, EWELINA, et al.
Publicado: (2016)

Different mutational characteristics of TSG in cell lines and surgical specimens
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation
por: Stec, Wojciech, et al.
Publicado: (2018)

Limited importance of the dominant-negative effect of TP53 missense mutations
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2011)

Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors
por: Nishino, Koichiro, et al.
Publicado: (2018)

Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells
por: Wlodarczyk, Aneta, et al.
Publicado: (2020)

PIN3 duplication may be partially responsible for TP53 haploinsufficiency
por: Winiecka-Klimek, Marta, et al.
Publicado: (2014)

Cell line with endogenous EGFR(vIII) expression is a suitable model for research and drug development purposes
por: Stec, Wojciech J., et al.
Publicado: (2016)

Long-term transgene expression and inhibition of HIV-1 replication by a Cre/loxP-EBNA-1/oriP HIV-1-dependent ribozyme vector: Applications for HIV-1 gene therapy
por: Nagawa, Takashi, et al.
Publicado: (2006)

The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

EGFR(vIII): An Oncogene with Ambiguous Role
por: Rutkowska, Adrianna, et al.
Publicado: (2019)

Role of Senescence in Tumorigenesis and Anticancer Therapy
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2022)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
por: Jiang, Aiwen, et al.
Publicado: (2022)

Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
por: Zuo, Yufang, et al.
Publicado: (2011)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs
por: Komatsu, Yumiko, et al.
Publicado: (2019)

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
por: Bieńkowski, Michał, et al.
Publicado: (2013)

iPSCs-based generation of vascular cells: reprogramming approaches and applications
por: Klein, Diana
Publicado: (2017)

Reprogramming efficiency and pluripotency of mule iPSCs over its parents
por: Zhang, Jia, et al.
Publicado: (2023)

Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
por: Piaskowski, S, et al.
Publicado: (2011)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors
por: Wen, Wei, et al.
Publicado: (2016)

Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy
por: Tręda, Cezary, et al.
Publicado: (2023)

Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats
por: Aiyar, Ashok, et al.
Publicado: (2009)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
por: Witusik-Perkowska, Monika, et al.
Publicado: (2010)

Manipulation of KLF4 Expression Generates iPSCs Paused at Successive Stages of Reprogramming
por: Nishimura, Ken, et al.
Publicado: (2014)

Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature
por: Thomas, Samantha M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i03fc3f9kcutfrg2du0sgotaam